Your browser doesn't support javascript.
loading
Idecabtagene Vicleucel Is Well Tolerated and Effective in Relapsed/Refractory Myeloma Patients with Prior Allogeneic Stem Cell Transplantation.
John, Lukas; Sauer, Sandra; Hegenbart, Ute; Dreger, Peter; Hundemer, Michael; Müller-Tidow, Carsten; Schmitt, Anita; Schmitt, Michael; Raab, Marc S; Schönland, Stefan O.
Afiliação
  • John L; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany.
  • Sauer S; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Hegenbart U; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Dreger P; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Hundemer M; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Müller-Tidow C; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany; National Center for Tumor Diseases, Heidelberg, Germany.
  • Schmitt A; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Schmitt M; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Raab MS; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany.
  • Schönland SO; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany. Electronic address: stefan.schoenland@med.uni-heidelberg.de.
Transplant Cell Ther ; 29(10): 609.e1-609.e6, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37348705

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha